Medline Reports Fourth Quarter and Full Year 2025 Results with Sales Growth and Net Income Decline

Summary

Medline Inc. reported strong fourth quarter and full year 2025 results, with net sales increasing by 14.8% to $7.8 billion and 11.5% to $28.4 billion, respectively. However, net income decreased due to higher costs, leading to a 37.7% drop in fourth quarter net income and a 3.6% decrease for the full year. The company also announced new customer signings of $2.4 billion for 2025 and provided guidance for 2026 Organic Sales growth of 8% to 9% and Adjusted EBITDA of $3.5 to $3.6 billion.